MS. Ethanol excitation of dopaminergic ventral tegmental area neurons is blocked by quinidine.
Liu, Zhaoping, E. Bradshaw Bunney, Sarah B. Appel, and Mark S. Brodie. Serotonin reduces the hyperpolarization-activated current (I h ) in ventral tegmental area dopamine neurons: involvement of 5-HT 2 receptors and protein kinase C. J Neurophysiol 90: 3201-3212, 2003 . First published July 30, 2003 10.1152 /jn.00281.2003 . Dopaminergic neurons of the ventral tegmental area (VTA) have been implicated in the rewarding properties of drugs of abuse and in the etiology of schizophrenia; serotonin modulation of these neurons may play a role in these phenomena. Whole cell patch-in-the-slice recording in rat brain slices was used to investigate modulation of the hyperpolarization-activated cationic current I h by serotonin in these neurons. Serotonin (50 -500 M) reduced the amplitude of I h in a concentration-dependent manner; this effect was reversible after prolonged washout of serotonin. This effect was mimicked by the 5-HT 2 agonist ␣-methylserotonin (25 M) and reversed by the 5-HT 2 antagonist ketanserin (25 M). Serotonin reduced the maximal I h current and conductance (measured at Ϫ130 mV) and caused a negative shift in the voltage dependence of I h activation. The serotonin-induced reduction in I h amplitude was antagonized by intracellular administration of the nonspecific protein kinase inhibitor H-7 (75 M) and the selective protein kinase C inhibitor chelerythrine (25 M). The protein kinase C activator phorbol 12, 13 diacetate (PDA, 2 M) reduced I h amplitude; when PDA and serotonin were applied together, the effect on I h was less than additive. These data support the conclusion that serotonin reduces I h in dopaminergic VTA neurons by acting at serotonin 5-HT 2 receptors, which activate protein kinase C. This reduction of I h may be physiologically important, as the selective inhibitor of I h , ZD7288, significantly increased dopamine inhibition of firing rate of dopaminergic VTA neurons, an effect that we previously demonstrated with serotonin.
I N T R O D U C T I O N
Dopaminergic neurons of the ventral tegmental area (VTA) have been implicated in the rewarding effects of drugs of abuse (Wise 1987) and in the etiology of schizophrenia (White and Wang 1983) . Dopaminergic neurons in the VTA are the cells of origin of the mesolimbic/mesocortical dopamine pathways and provide dopaminergic innervation of the nucleus accumbens (Oades and Halliday 1987) . The mesolimbic/mesocortical dopamine pathway is important for self-administration of most drugs of abuse including, cocaine, amphetamine, nicotine, and ethanol (Wise 1987) . The rewarding properties of some drugs of abuse, for example ethanol and nicotine, are related to their ability to excite dopaminergic cell bodies in the VTA (Brodie 1991; Brodie et al. 1999b; Di Chiara and Imperato 1988) .
The VTA receives serotonergic innervation from the raphe nuclei (Oades and Halliday 1987) . Serotonin has many effects in the VTA. Serotonin acts on 5-HT 1D receptors to reduce GABA release from GABAergic terminals onto GABA B receptors on dopaminergic neurons (Cameron and Williams 1994) . Serotonin potentiates ethanol excitation (Brodie et al. 1995; Trifunovic and Brodie 1996) and dopamine inhibition (Brodie and Bunney 1996) of dopaminergic VTA neurons, and both of these effects are mediated by 5-HT 2 receptors. Cocaine also potentiates ethanol excitation of these neurons, an effect also mediated by 5-HT 2 receptors (Bunney et al. 2000) .
Dopaminergic VTA neurons have a hyperpolarization-activated cationic current (I h ) (Lacey et al. 1989; Mueller and Brodie 1989) . I h has been shown to be modulated by serotonin in a number of different types of neurons. Serotonin increases I h in neurons in the thalamus (McCormick and Pape 1990) , nucleus prepositus hypoglossi (Bobker and Williams 1989) and dorsal root ganglion (Cardenas et al. 1999) , and these effects of serotonin are mediated by an increase in cAMP. Serotonin also increases I h in motoneurons of the facial motor nucleus but through an action at 5-HT 2 receptors (Garratt et al. 1993) . In contrast to the enhancement seen in the preceding studies, serotonin decreases I h in cerebellar Purkinje neurons, an effect that may be mediated by 5-HT 2 receptors (Li et al. 1993) .
In earlier reports on the action of serotonin on dopaminergic neurons, serotonin was observed to increase I h in substantia nigra neurons (Nedergaard et al. 1991) and in 25% of VTA neurons tested (Pessia et al. 1994) . In our studies, serotonin potentiation of the effects of ethanol (Brodie et al. 1995) and dopamine (Brodie and Bunney 1996) was mediated through 5-HT 2 receptors and generally required higher serotonin concentrations or longer administrations of serotonin than were applied by others (Pessia et al. 1994) . For this reason, we assessed the effects of higher serotonin concentrations on I h . The present study demonstrates that serotonin reduces the amplitude of I h in dopaminergic VTA neurons in a concentration-dependent manner and causes a negative shift in the voltage dependence of I h activation. Furthermore, this effect of serotonin appears to be mediated by 5-HT 2 receptors and activation of protein kinase C. Some of these results have been previously reported in abstract form (Liu et al. 1999) .
M E T H O D S

Preparation of brain slices
Brain slices containing the VTA were prepared from male Fischer 344 rats (90 -150 g) as previously described (Brodie et al. 1999a) . Animals used in this study were treated in strict accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Briefly, after rapid removal of the brain, the tissue was blocked coronally to contain the VTA and substantia nigra; the cerebral cortices and a portion of the dorsal mesencephalon were removed from the block. The tissue block was glued to the vibratome chuck and submerged in chilled artificial cerebrospinal fluid (ACSF). Coronal sections (400 m thick) were cut, and the tissue was placed directly in the recording chamber (500 l). The slice was totally submerged in ACSF maintained at a flow rate of 2 ml/min; the temperature in the recording chamber was kept at 35°C. The composition of the ACSF in these experiments was (in mM) 126 NaCl, 2.5 KCl, 1.24 NaH 2 PO 4 , 2.4 CaCl 2 , 1.3 MgSO 4 , 26 NaHCO 3 , and 11 glucose. The ACSF was saturated with 95% O 2 -5% CO 2 (pH ϭ 7.4). Equilibration time of Ն1 h was allowed after placement of tissue in the recording chamber before electrodes were placed in the tissue. The VTA was clearly visible in the fresh tissue as a gray area medial to the darker substantia nigra, and separated from the nigra by white matter. Recording electrodes were placed in the VTA under visual control.
Cell identification
Dopamine neurons have been shown to have electrophysiological characteristics very different from nondopaminergic neurons in the mesencephalon (Grace and Bunney 1984; Lacey et al. 1989) . Only those neurons that were anatomically located within the VTA and that conformed to the criteria for dopaminergic neurons established in the literature and in this laboratory (Lacey et al. 1989; Mueller and Brodie 1989) were studied. These criteria include broad action potentials, slow spontaneous firing rate (0.5-5 Hz) with a regular interspike interval, and the presence of time-dependent inward rectification due to the presence of the hyperpolarization-activated cationic current (I h ).
Whole cell recording
Patch electrodes were pulled from LE16 glass capillaries (Dagan, Minneapolis, MN) and the tips were fire-polished. Electrodes had resistances of 3-5 M⍀ when filled with a solution containing (in mM) 125 potassium gluconate, 15 NaCl, 1 CaCl 2 , 2 MgCl 2 , 10 HEPES, 11 EGTA, 3 ATP, and 0.3 GTP, adjusted to pH 7.3 with TRIZMA base. The electrode was advanced into the brain slice, and the extracellular spontaneous action potentials of dopaminergic VTA neurons were monitored in current clamp mode. Recordings were made with conventional whole cell patch-in-the-slice methodology. Voltage-and current-clamp recordings were accomplished with an Axopatch-1B or Axoclamp-2A amplifier (Axon Instruments, San Rafael, CA). Current and voltage were monitored on a storage oscilloscope and on a rectilinear pen recorder and recorded on an on-line PC computer. Current and voltage steps, data acquisition and data analysis were controlled with pClamp 8 software (Axon Instruments, Foster City, CA).
Protocols and data analysis
In current-clamp experiments, I h was evoked by a family of hyperpolarizing current pulses (duration: 800 ms); the largest current pulse was adjusted to cause a peak voltage deflection to about Ϫ120 mV. Voltage-current (V-I) curves were constructed for peak and steady-state voltage responses. The voltage change due to I h was measured as the difference between the peak voltage and the steady-state voltage at the end of the current pulse. In voltage-clamp experiments, I h was evoked with a family of hyperpolarizing voltage steps (duration: 1 s) from a holding potential of -60 to -130 mV (in 10-mV increments). Current-voltage (I-V) curves were constructed for instantaneous and steady-state currents. The amplitude of I h was measured as the difference between the instantaneous current measured just after the decay of the capacitive transient and the steady-state current at the end of the voltage step; I h -V curves were constructed from these data.
The reversal potential of I h was determined from tail currents measured with the following voltage protocol. The membrane potential was stepped to Ϫ110 mV from a holding potential of Ϫ60 mV to activate I h ; the step duration was 1 s that was sufficient time for full activation. The membrane potential was then stepped to test voltages between Ϫ120 and Ϫ10 mV (in 10-mV increments); step duration was 300 ms. The maximum amplitude of the tail current was measured just after the capacitive transient at each test voltage. Tail current amplitude was plotted as a function of the test voltage step, a curve fitted to the data points and the reversal potential was determined from the point on the curve at which the tail current reversed from outward to inward. To reduce contamination of I h tail currents by other currents, tail current experiments were performed in the presence of tetrodotoxin (TTX, 1 M), tetraethylammonium chloride (TEA, 2 mM), 4-aminopyridine (2 mM), and MgCl 2 (20 mM) in the ACSF.
Drug-induced changes in I h were evaluated by examination of full I-V and I h -V curves measured in control and in the presence of drug in the same VTA neuron. For the purposes of averaging responses from different neurons and comparisons between drug conditions, drug-induced changes in I h were summarized as the percent decrease in I h amplitude measured at Ϫ120 mV. Percent decrease in I h was calculated as [(A D Ϫ A C )/A C ] ϫ 100, where A D is the amplitude of I h measured in the presence of the drug and A C is the amplitude of I h measured in control medium in the same cell prior to drug administration. Averaged data are expressed as means Ϯ SE. Statistical significance of data from different drug conditions was assessed with a Student's t-test or one-or two-way ANOVA as appropriate. When needed, the Student-Newman-Keuls post hoc test was used to test all pairwise multiple comparisons, and the Dunnett's post hoc test was used for multiple comparisons versus the control group.
Extracellular recording
Extracellular recording electrodes were made from 1.5-mm-diam glass tubing with filament and were filled with 0.9% NaCl. Tip resistance of the microelectrodes ranged from 4 to 8 M⍀. The Fintronics amplifier used in these recordings includes a window discriminator, the output of which was fed to both a rectilinear pen recorder, and a computer-based data-acquisition system that was used for onand off-line analysis of the data. The multiplexed output of the Fintronics amplifier was displayed on an analog storage oscilloscope for accurate adjustment of the window levels used to monitor single units. An IBM-PC-based data-acquisition system was used to calculate, display, and store the frequency of firing over 5-s and 1-min intervals. Firing rate was determined before and during drug application. Firing rate was calculated over a 1-min interval immediately prior to drug administration and a 1-min interval during the peak drug effect; drug-induced changes in firing rate were expressed as the percentage change from the control firing rate according to the formula [(FR D Ϫ FR C )/FR C ] ϫ 100, where FR D is the firing rate during the peak drug effect and FR C is the control firing rate. The change in firing rate thus is expressed as a percentage of the initial firing rate, which controls for small changes in firing rate which may occur over time.
Drugs
The flow rate of fluid to the recording chamber was continuously monitored with a flowmeter, and adjustable valves were used to keep the rate constant. The small volume chamber used in this study permitted the rapid application and washout of drug solutions. Because the slice was submerged in ACSF in the recording chamber, applied agents reach equilibrium in the chamber quickly (2-3 min). Drugs were added to the ACSF in the fluid delivery tubing by means of a calibrated infusion pump from stock solutions 100 -1,000 times the desired final concentrations. The addition of drug solutions to the ACSF was performed in such a way as to permit the drug solution to mix completely with ACSF before this mixture reached the recording chamber. Final concentration was calculated from ACSF flow rate, pump infusion rate, and concentration of drug stock solution. Effects on I h were measured at 5 and 10 min after bath application of serotonin. In general, the effect on I h was greater at 10 min, and therefore the data shown in this paper were collected at this time point. Dopamine was given for 6 min, or less if firing rate was completely blocked. ZD7288 was given for 20 min before dopamine was retested. Most other drugs were administered by bath application as described in the preceding text and their effects on I h were quantitated after 10 min of application. The exceptions to this were H-7, chelerythrine, and cAMP, which were added to the internal solution and were applied intracellularly from the recording pipette. In this case, a period of 10 -20 min was allowed after the rupture of the patch to permit the drug to enter the cell.
Serotonin creatinine sulfate complex, ␣-methylserotonin maleate, ketanserin tartrate, dopamine hydrochloride, and all other drugs used in this study were obtained from Sigma/RBI (St. Louis, MO) except for H-7 and dibutyryl-cAMP, which were obtained from Tocris Cookson, (Ballwin, MO); tetrodotoxin (TTX), which was used only in the tail-current experiments, was obtained from Calbiochem (La Jolla, CA).
R E S U L T S
Serotonin reduces I h : current-clamp studies
Initially, I h was studied in current clamp mode in a total of 21 VTA neurons with whole cell patch-in-the-slice recording. All cells met the criteria for dopaminergic VTA neurons described in METHODS. At the resting membrane potential, these cells fired overshooting spontaneous action potentials. When tested with a series of hyperpolarizing current pulses 800 ms in duration (Fig. 1A, top) , all of these neurons exhibited a robust time-dependent depolarizing "sag" in voltage responses more negative than about Ϫ70 mV (Fig. 1A, bottom) , due to activation of I h . The difference between the peak and steady-state voltage response indicates the magnitude of I h . In the presence of 300 M serotonin, the difference between the peak and steady-state voltage response was reduced, showing that I h is reduced by serotonin in these dopaminergic VTA neurons ( Fig.  1B) . Figure 1C is a voltage-current (V-I) curve in which the voltage responses shown in Fig. 1, A and B , are plotted as a function of the negative current pulses used to evoke them. This graph shows that serotonin produced a relatively small change in the peak voltage response but produced a large reduction in the steady-state response. Figure 1D plots the difference between the peak and steady-state voltage responses (magnitude of I h ) as a function of the peak voltage attained. This graph clearly shows the reduction in I h over the voltage range from about Ϫ70 to Ϫ120 mV.
The serotonin-induced reduction of I h in dopaminergic VTA neurons was concentration dependent (n ϭ 21). Figure 2 illustrates the effect of four different concentrations of serotonin tested on a dopaminergic VTA neuron. Figure 2A is a V-I curve showing the effect of serotonin on the peak and steady-state components of the voltage responses in this neuron, and B FIG. 1. Serotonin effect on voltage responses and reduction of I h . Voltage responses of a dopaminergic ventral tegmental area (VTA) neuron evoked by a series of hyperpolarizing current pulses in increments of 30 pA before (A) and in the presence (B) of 300 M serotonin. The voltage response reached a peak followed by a depolarizing sag. Serotonin (300 M) decreased the amplitude of the sag indicating inhibition of I h .C: voltage-current (V-I) curves in the absence (E and ‚) and presence (F and OE) of 300 M serotonin. The peak (pk) and steady-state (ss) amplitude of voltage responses (from A and B) are plotted as a function of the current amplitude used to evoke them. Compared with control, 300 M serotonin reduced the steady-state voltage responses but had only a small effect on peak voltage responses. D: the difference between the peak and steady-state voltage (⌬ voltage) was plotted as a function of the peak voltage attained for the response to each current pulse (same neuron as in A-C). Note that the voltage difference between peak and steady-state increased progressively at peak voltages more negative than -70 mV, which is the voltage range for activation of I h . Serotonin (300 M, F) decreased the voltage difference between peak and steadystate as compared with control (E) indicating a reduction in I h . shows the voltage difference between peak and steady-state as a measure of the magnitude of I h in the same neuron. Serotonin (50 -500 M) caused a concentration-dependent reduction in the steady-state current, but little change in the peak voltage ( Fig. 2A ). Figure 2B shows that this corresponds to a concentration-dependent reduction in the magnitude of I h . In all nine cells tested with more than one serotonin concentration (100 -500 M) in current-clamp experiments, higher concentrations of serotonin produced a larger decrease in I h than the lower concentrations. Table 1 shows the effects of serotonin (50 -500 M) on 21 dopaminergic VTA neurons; with concentrations of Ն100 M, Ͼ90% of the neurons showed a reduction in I h . No cell exhibited a serotonin-induced increase in I h , but a few showed no change in I h , including four cells tested with 25 M serotonin.
For the population of cells tested with 300 M serotonin (n ϭ 15), serotonin did not significantly change the membrane potential (paired t-test, P Ͼ 0.05) or the input resistance (paired t-test, P Ͼ 0.05). Specifically, prior to serotonin administration, the mean membrane potential was Ϫ51.3 Ϯ 1.1 mV and the mean input resistance was 291 Ϯ 52 M⍀; in the presence of 300 M serotonin, the mean membrane potential was Ϫ50.2 Ϯ 1.2 mV and the mean input resistance was 319 Ϯ 46 M⍀.
As has been previously shown (Cathala and Paupardin-Tritsch 1997; Jiang et al. 1993) , the I h measured in this study was blocked by addition of cesium to the external medium. Cesium (2.5 mM) caused complete block of I h in five of nine dopaminergic VTA neurons and partial block in the remaining four neurons (data not shown). I h was completely blocked by 5 mM cesium (Appel et al. 2003) .
Voltage-clamp characterization of the serotonin-induced reduction of I h
Following the current-clamp studies described in the preceding text, the effect of serotonin on I h was further characterized with whole cell voltage-clamp recording in a total of 40 dopaminergic VTA neurons in brain slices. Voltageclamp recording allowed the effect of serotonin on I h to be studied at constant voltage and allowed determination of the effect of serotonin on the voltage dependence of activation of I h (see Fig. 7 , following text). The mean membrane potential of these neurons (measured in current-clamp mode) was Ϫ44.4 Ϯ 0.5 mV, and the mean input resistance was 108.6 Ϯ 4.5 M⍀ (n ϭ 40). Figure 3A illustrates the currents recorded in response to a series of negative voltage steps (duration: 1 s) from a holding potential Ϫ60 to Ϫ130 mV (in 10 mV increments). Following the capacitive artifact, there was a time-dependent increase in inward current reflecting the activation of I h (bottom). The instantaneous current (ins.; 1) was measured just after the decay of the capacitive transient and the steady-state current (ss.; 1) was measured near the end of the voltage command. Figure 3B shows that in the presence of 500 M serotonin, the steadystate inward current was substantially reduced in comparison to control (Fig. 3A) , reflecting a serotonin-induced decrease in I h . Figure 3C is a current-voltage (I-V) curve of the instantaneous and steady-state currents plotted as a function of the step voltage, in control (data from Fig. 3A ) and in the presence of 500 M serotonin (data from Fig. 3B ). Note that serotonin decreased the steady-state current at all voltage steps more negative than -70 mV but had little or no effect on the instantaneous current. In Fig. 3D , the difference between the instantaneous and steady-state current (amplitude of I h ) is plotted versus the step voltage in the absence and presence of 500 M serotonin. Note that I h exhibited inward rectification and was activated at potentials more negative than -70 mV. The large reduction in I h caused by the addition of 500 M serotonin can be clearly seen. 15 (100) 0 (0) 0 (0) 15 500 6 (100) 0 (0) 0 (0) 6
Each neuron was tested with from one to four different concentrations of serotonin. When multiple concentrations were tested on the same neuron, the order of administration was from lowest to highest and each concentration was applied for 10 -15 min before increasing the concentration. The number of cells showing each type of response is listed with the percent response of all cells tested with the same concentration given in parentheses. VTA; ventral tegmental area. Fig. 1C show the peak and steady-state voltage responses evoked by a series of hyperpolarizing current pulses in control and in the presence of 4 different concentrations of serotonin in a single dopaminergic VTA neuron. Serotonin (5-HT, 50 -500 M) caused a concentration-dependent reduction in the steady-state voltage responses (steady-state: symbols in legend) but had no effect on the peak responses (peak: symbols in legend). B: the magnitude of I h in this neuron was determined from the difference between the peak and steady-state voltage responses and is plotted as in Fig. 1D . Serotonin (50 -500 M) caused a concentration-dependent decrease in the magnitude of I h at all potentials negative to -70 mV. Figure 4 shows the concentration dependence of serotonin reduction of I h under voltage-clamp conditions. Figure 4A is an I-V curve showing the instantaneous and steady-state currents plotted as a function of the hyperpolarizing voltage step; the currents were measured in control and after bath applications of three different concentrations of serotonin (100, 300, and 500 M) to the same neuron. Serotonin (100 -500 M) decreased the steady-state current in a concentration-dependent manner but did not affect the instantaneous current. The difference between the instantaneous and steady-state current, I h , is plotted as a function of voltage in Fig. 4B ; the concentration dependence of the reduction of I h by serotonin can be seen clearly in this graph. In all five cells tested with more than one serotonin concentration (Ն100 M) in voltage-clamp experiments, higher concentrations of serotonin produced a larger decrease in I h than the lower concentrations. A concentration-response curve for the mean serotonin-induced reduction of I h in voltage-clamp experiments is illustrated in Fig. 4C . The effect of serotonin was concentration-dependent (1-way ANOVA, F ϭ 12.47, df ϭ 2, 36, P Ͻ 0.001). Table 2 shows that serotonin (30 -500 M) reduced I h in most of the 40 cells tested under voltage-clamp conditions. With serotonin concentrations of Ն50 M, Ͼ90% of the neurons showed a reduction in I h , no neurons exhibited an increase in I h , and two neurons showed no change. By contrast, 30 M serotonin (tested on 16 neurons) produced an increase in I h in 37.5% of the cells, a decrease in ϳ37.5%, and no change in the remaining 25% of the neurons.
When the recording could be held for sufficient time, the effect of serotonin was completely reversible. Figure 5 illustrates such an experiment. In this neuron, 300 M serotonin clearly reduced the amplitude of I h , and after a washout period of 1 h, I h returned to the pre-serotonin levels. Partial or total recovery on washout was observed in six neurons. For the six neurons tested, before serotonin administration I h at Ϫ130 mM was Ϫ288 Ϯ 0.05 pA, in the presence of serotonin, I h at Ϫ130 mV was Ϫ202 Ϯ 0.05 pA, and on washout of from 20 to 60 min, I h at Ϫ130 mV was Ϫ279 Ϯ 0.05 pA. Serotonin significantly reduced I h amplitude (1-way repeated measures ANOVA, F ϭ 5.60, df ϭ 2, 10; P Ͻ 0.05), but there was no significant difference in I h at Ϫ130 mV between control and washout values (Student-Newman-Keuls, P Ͼ 0.05).
Effect of serotonin is mimicked by ␣-methylserotonin
The effect of serotonin to reduce I h was seen primarily at concentrations Ͼ50 M. One reason for this could be efficient serotonin reuptake in the brain slice preparation, which would reduce the effective concentration of serotonin at the receptor. We have previously demonstrated serotonergic effects on ethanol potency with low concentrations of the reuptake inhibitors cocaine and cocaethylene in the absence of exogenous serotonin (Bunney et al. 2000 (Bunney et al. , 2001 , indicating that both release of serotonin and active reuptake of endogenous serotonin occur in our slice preparation. Because the results of experiments using reuptake blockers in combination with exogenous serotonin would be difficult to interpret due to unknown levels of endogenous serotonin, we used a serotonin analog that is not a substrate for reuptake, ␣-methylserotonin (␣-Me5-HT). Figure 6 ; 1) was measured just after the decay of the capacitive transient and the steady-state current (ss.; 1) was measured near the end of the voltage command. B: bath application of serotonin (500 M) greatly reduced the amplitude of the steady-state current responses evoked with the same voltage protocol (same neuron as in A). C: current-voltage (I-V) curves showing the instantaneous (F and E) and steadystate (OE and ‚) currents as a function of the step voltage, in control (E and ‚) and in the presence of 500 M serotonin (F and OE). Serotonin decreased the steady-state current at all voltage steps negative to -70 mV but had little or no effect on the instantaneous current. D: the difference between the instantaneous and the steady-state currents (amplitude of I h ) is plotted vs. step voltage, in the absence (E) and presence (F) of 500 M serotonin.
Ϫ7.69, df ϭ 7, P Ͻ 0.001). The mean percent decrease in I h amplitude caused by 25 M ␣-Me5-HT was Ϫ19.7 Ϯ 2.8% (n ϭ 8), which was similar in magnitude to the mean percent decrease caused by 100 M serotonin Ϫ22.1 Ϯ 4.3% (n ϭ 5).
This effect of ␣-methylserotonin was reversible after 30 -40 min of washout (Fig. 6B ) in all three dopaminergic VTA neurons tested. Specifically, ␣-Me5-HT (25 M) significantly decreased the mean I h amplitude measured at Ϫ120 mV from Ϫ258 Ϯ 5 pA in control to Ϫ197 Ϯ 6 pA in ␣-Me5-HT and then fully reversed with washout to Ϫ251 Ϯ 16 pA (1-way repeated-measures ANOVA, F ϭ 14.64, df ϭ 2, 4, P ϭ 0.014, Student-Newman-Keuls post hoc tests, P Ͻ 0.05).
Effect of ␣-methylserotonin is reversed by ketanserin
Because ␣-methylserotonin is a selective agonist for the 5-HT 2 receptor, the preceding results suggest that the 5-HT 2 serotonin receptor mediates the inhibitory effect of serotonin on I h . To further establish this, we tested whether ketanserin, a selective 5-HT 2 antagonist, could reverse the reduction of I h by ␣-methylserotonin; this was found to be the case in all three dopaminergic VTA neurons tested. Specifically, ␣-Me5-HT (25 M) significantly decreased the mean I h amplitude measured at Ϫ120 mV from Ϫ354 Ϯ 39 pA in control to Ϫ302 Ϯ 55 pA in ␣-Me5-HT. When ketanserin (25 M) was added to the superfusate in the continued presence of ␣-Me5-HT, the effect of ␣-Me5-HT was fully reversed. In the presence of both ketanserin and ␣-Me5-HT, the mean I h amplitude was Ϫ393 Ϯ 37 pA, which was significantly larger than in the presence of ␣-Me5-HT alone (1-way repeated-measures ANOVA, F ϭ 21.44, df ϭ 2, 4, P ϭ 0.007, Student-Newman-Keuls post hoc tests P Ͻ 0.05). and steady-state (filled symbols) currents plotted as a function of the hyperpolarizing voltage step for a typical dopaminergic VTA neuron. Current responses were measured in control and after bath applications of 3 different concentrations of serotonin (5-HT, 100, 300, and 500 M) to the same neuron (symbols on legend). Serotonin (100 -500 M) decreased the steady-state currents in a concentration-dependent manner but did not affect the instantaneous currents. B: I h , the difference between the instantaneous and steady-state currents, was inhibited in a concentration-dependent manner by serotonin (100 -500 M); same neuron as in A. C: pooled concentration-response curve for the effect of serotonin on I h amplitude in voltage-clamp experiments. The amplitude of I h at a command voltage of Ϫ120 mV was measured by subtracting the instantaneous current from the peak current and expressed as percent change from control I h amplitude (see METHODS). One or more concentrations of serotonin (30, 100, or 300 M) was applied to 18 dopaminergic VTA neurons and the mean change in I h was plotted as a function of serotonin concentration (ϮSE). 2 (100) 0 (0) 0 (0) 2
Each neuron was tested with from one to four different concentrations of serotonin. When multiple concentrations were tested on the same neuron, the order of administration was from lowest to highest and each concentration was applied for 10 -15 min before increasing the concentration. The number of cells showing each type of response is listed with the percent response of all cells tested with the same concentration given in parentheses. 
Serotonin causes a negative shift in the voltage-dependence of I h activation
I h was measured in 10 dopaminergic VTA neurons in the absence and presence of 300 M serotonin. The voltage-clamp protocol and data analysis were the same as described for Fig.  3 in the preceding text. I h currents were converted to conductance (G h ) with the equation
, where E is the voltage step used to evoke the current and E rev is the reversal potential of I h . The values for E rev were Ϫ39 mV for control and Ϫ42 mV for serotonin as determined by tail current analysis in three cells (see METHODS). The mean maximal G h conductance (G h measured at Ϫ130 mV) was 3.3 Ϯ 0.4 nS in control and 1.7 Ϯ 0.2 nS in 300 M serotonin (n ϭ 10) or a mean percent reduction in maximal conductance of Ϫ47% (with each cell serving as its own control). This serotonininduced reduction in maximal G h was significant (paired t-test, t ϭ 4.75, df ϭ 9, P ϭ 0.001).
The conductance (G h ) for each cell was normalized (G h / G max ), where G max was taken to be the value of G h at Ϫ130 mV; this was done to permit the pooling of responses from the 10 neurons, as shown in Fig. 7 . The mean normalized conductance (G h /G max ) in the absence and presence of serotonin (300 M) is plotted as a function of voltage. Serotonin shifted this conductance-voltage curve in the negative direction, indicating a negative shift in the voltage dependence for activation of G h . The serotonin-induced shift was statistically significant (2-way ANOVA, F ϭ 10.69, df: 1, 126, P ϭ 0.001). The effect of voltage was also significant (F ϭ 167.57, df ϭ 6, 126, P Ͻ 0.001). The smooth curves on Fig. 7 were fit to the data points with the Boltzmann equation of the form
The half-activation voltage (V 1/2 ) determined from the Boltzmann equation was Ϫ88 Ϯ 0.6 mV in control and Ϫ95 Ϯ 1.6 mV in 300 M serotonin, a negative shift of ϳ7 mV (Fig. 7) . The slope factor (k) was similar in control (12 Ϯ 0.6) and in serotonin (11 Ϯ 1.5).
Effect of cAMP agonists and protein kinase inhibitors on the serotonin-induced reduction of I h
Drug-induced changes in I h were evaluated by examination of full I-V and I h -V curves measured in control and in the presence of drug in the same VTA neuron. For the purposes of averaging responses from different neurons and comparisons between drug conditions, drug-induced changes in I h were summarized as the percent decrease in I h amplitude measured at Ϫ120 mV (see METHODS for formula). We first examined whether increasing intracellular cAMP would alter the serotonin-induced reduction of I h . Bath application of serotonin alone (300 M) caused a mean percent decrease in I h amplitude of Ϫ39.1 Ϯ 5.6% in 12 dopaminergic VTA neurons (Fig. 8, far  left bar) . In another group of dopaminergic VTA neurons, 1 mM cAMP was included in the recording pipette. A small increase in the amplitude of I h was seen after 10 -15 min of recording in all five of these neurons, indicating that cAMP had diffused into the cell and was exerting a positive modulatory effect on I h . Figure 8 shows that after 10 -15 min of intracel- E rev ) , where E is the voltage step used to evoke the current and E rev is the reversal potential of I h . The values for E rev , which were calculated by tail current analysis, were Ϫ39 mV in control and Ϫ42 mV in 300 M serotonin (see METHODS for details). The conductance (G h ) for each cell was normalized (G h /G max ), where G max was taken to be the value of G h at Ϫ130 mV. The mean normalized conductance (G h /G max Ϯ SE) in the absence (E) and presence (F) of serotonin (300 M) is plotted as a function of voltage. Serotonin shifted this curve in the negative direction indicating a negative shift in the voltage dependence for activation of G h . This shift was statistically significant (n ϭ 10, 2-way ANOVA, P ϭ 0.001). The half-activation voltage (V 1/2 ) determined from the Boltzmann equation fit to the data was Ϫ88 mV in control and Ϫ95 mV in 300 M serotonin, a negative shift of ϳ7 mV. The smooth curves show the Boltzmann fit to the data points. lular administration of 1 mM cAMP, bath application of 300 M serotonin still reduced I h amplitude, causing a mean percent decrease of Ϫ32.5 Ϯ 7.1% (n ϭ 5). The effect of serotonin was also tested after 10 min of bath application of the membrane permeable cAMP analogue dibutyryl-cAMP. Serotonin (300 M) also reduced I h amplitude when applied in the presence of 500 M dibutyryl-cAMP (Ϫ27.5 Ϯ 4.7%, n ϭ 3).
The involvement of protein kinases A and C in the serotonin-induced reduction in I h was tested with the nonspecific protein kinase inhibitor H-7 (Hidaka et al. 1984 ) and the selective protein kinase C inhibitor chelerythrine (Herbert et al. 1990) . When the nonspecific protein kinase inhibitor H-7 (75 M) was included in the recording pipette, there was no change in I h amplitude after 20 min of recording (n ϭ 4). Subsequent bath application of 300 M serotonin caused only a very small mean percent decrease in I h amplitude at Ϫ120 mV (Ϫ4.4 Ϯ 11.0%, n ϭ 4). Likewise, when the protein kinase C inhibitor chelerythrine (25 M) was included in the recording pipette, there was no consistent change in I h amplitude after 10 min of recording (n ϭ 7). Subsequent application of 300 M serotonin reduced I h amplitude measured at Ϫ120 mV by (Ϫ16.2 Ϯ 3.8%, n ϭ 7), a much smaller reduction than the effect of serotonin alone. There was a significant difference among the drug conditions shown in Fig. 8 (1-way ANOVA, F ϭ 4.2, df: 4, 26, P ϭ 0.009), and Dunnett's post hoc comparisons demonstrated that the effect of serotonin in the presence of internal cAMP or external dibutyryl-cAMP was not significantly different from serotonin alone (P Ͼ 0.05), but there was a significant difference between the control effect of serotonin alone and the effect of serotonin in the presence of H-7 or chelerythrine (P Ͻ 0.05). Because both H-7 and cheleryrine significantly attenuated the serotonin-induced reduc-tion of I h and both are potent inhibitors of protein kinase C, the following experiments with the phorbol ester, PDA, were undertaken to further examine the possible involvement of protein kinase C. Figure 9A shows a current-voltage (I-V) curve of instantaneous and steady-state currents as a function of the step voltage in control and in the presence of 2 M PDA. DMSO (0.1%) was used as a vehicle for the PDA and was present both in control and in the PDA-containing media. Like the effect of serotonin shown in Fig. 3C , PDA decreased the steady-state current but had little or no effect on the instantaneous current. In Fig. 9B , the difference between the instantaneous and the steady-state currents (I h amplitude) is plotted versus the step voltage in the absence and presence of 2 M PDA. Note the large reduction in I h amplitude in the presence of PDA that closely resembles the effect of serotonin shown in Fig. 3D . Similar effects on I h current-voltage (I-V) curves were observed in all three dopaminergic VTA neurons tested with 2 M PDA. Figure 10 compares the effect on I h in dopaminergic VTA neurons of DMSO vehicle alone, serotonin (5-HT) in DMSO, PDA in DMSO, and 5-HT and PDA applied together in and steady-state (OE and ‚) currents as a function of the step voltage in control (E and ‚) and in the presence of 2 M PDA (F and OE). DMSO (0.1%) was used as a vehicle and was present both in control and in the PDA-containing media. Like the effect of serotonin shown in Fig. 3C , PDA decreased the steady-state current but had little or no effect on the instantaneous current. B: the difference between the instantaneous and the steady-state currents (I h amplitude) is plotted vs. the step voltage in the absence (E) and presence (F) of 2 M PDA. Note the large reduction in I h amplitude in the presence of PDA that closely resembles the effect of serotonin shown in Fig. 3D.   FIG. 8 . Effect of cAMP agonists and protein kinase inhibitors on the serotonin-induced reduction of I h . Bars indicate the mean Ϯ SE percent decrease in I h measured at Ϫ120 mV. Serotonin alone (5-HT, 300 M) reduced the amplitude of I h (Ϫ39.1 Ϯ 5.6%, n ϭ 12). Serotonin (300 M) also reduced I h amplitude in experiments in which 1 mM cAMP was included in the recording pipette (ϩcAMP, Ϫ32.5 Ϯ 7.1%, n ϭ 5). I h was also reduced when 300 M serotonin was applied in the presence of 500 M dibutyryl-cAMP (ϩdBcAMP, Ϫ27.5 Ϯ 4.7%, n ϭ 3), a membrane-permeable cAMP analogue. When the protein kinase inhibitor H-7 (75 M) was included in the recording pipette, 300 M serotonin caused only a very small mean percent decrease in I h amplitude (ϩH-7, Ϫ4.4 Ϯ 11.0%, n ϭ 4). Likewise, when the protein kinase C inhibitor chelerythrine (25 M) was included in the recording pipette, the reduction in I h amplitude by 300 M serotonin (ϩChelery, Ϫ16.2 Ϯ 3.8%, n ϭ 7) was much smaller than the effect of serotonin alone. There was a significant difference between the drug conditions (1-way ANOVA, P ϭ 0.009) and Dunnett's post hoc comparisons demonstrated a significant difference between the control effect of serotonin alone and the effect of serotonin in the presence of H-7 and chelerythrine (P Ͻ 0.05), but the effect of serotonin in the presence of internal cAMP or external dibutyryl-cAMP was not significantly different from serotonin alone (P Ͼ 0.05) .
Protein kinase C activator PDA mimics and occludes the serotonin-induced reduction in I h
DMSO. Bars indicate the mean percent decrease in I h measured at Ϫ120 mV (see METHODS for formula). The far left bar shows that addition of 0.1% DMSO to the ACSF did not change I h amplitude (Ϫ1.7 Ϯ 5.0%, n ϭ 7). DMSO (0.1%) was present in the ACSF for the other three experimental groups shown (remaining 3 bars). When tested in the presence of DMSO, 300 M serotonin caused a mean percent decrease in I h of Ϫ35.3 Ϯ 9.1% (n ϭ 4). Bath application of PDA (2 M) in DMSO vehicle also reduced I h amplitude (Ϫ44.9 Ϯ 7.8%, n ϭ 3). When PDA (2 M) and serotonin (300 M) were applied together (in DMSO), the mean percent decrease in I h amplitude was Ϫ51.5 Ϯ 20.0% (n ϭ 3). Note that this effect was much less than the sum of the effects of serotonin and PDA when tested alone. Asterisks indicate a significant difference from the effect of DMSO vehicle alone. (1-way ANOVA, F ϭ 6.72, df ϭ 3, 13, P ϭ 0.006; Student-Newman Keuls post hoc tests P Ͻ 0.02). The mean percent decreases in I h measured in 5-HT, PDA and 5-HT plus PDA were not significantly different from each other (P Ͼ 0.05).
Reduction of I h with ZD7288 potentiates dopamine inhibition
Because I h is activated at membrane potentials negative to Ϫ70 mV and the resting membrane potential of dopaminergic neurons is between Ϫ55 and Ϫ40 mV (Grace and Bunney 1983; Lacey et al. 1987) , the physiological relevance of reduction of I h by serotonin was examined. We previously have demonstrated that serotonin potentiates dopamine inhibition of the spontaneous firing rate of dopaminergic VTA neurons through an action at 5-HT 2 receptors (Brodie and Bunney 1996) . If serotonin potentiates dopamine inhibition through a reduction of I h , then selective blockade of I h also would be expected to potentiate dopamine inhibition. ZD7288 is a selective blocker of I h (Seutin et al. 2001 ). The spontaneous firing rate of dopaminergic VTA neurons was measured with extracellular single unit recording (see METHODS). Figure 11, A  and B , illustrates the effect of 30 M ZD7288 on dopamine inhibition of a single dopaminergic VTA neuron. For the population of cells tested before and in the presence of 30 M ZD7288 (n ϭ 14), dopamine produced concentration-dependent decreases in firing rate (2-way ANOVA, F ϭ 12.42, df ϭ 4,76; P Ͻ 0.001). ZD7288 alone increased the basal firing rate by 11.0 Ϯ 5.2%. The responses to dopamine (1-10 M) were much larger in the presence of 30 M ZD7288 than prior to ZD7288 addition in these cells (Fig. 11C) ; dopamine inhibition was significantly increased in the presence of ZD7288 compared with the control condition (2-way ANOVA, F ϭ 31.591, df ϭ 1,76; P Ͻ 0.001).
D I S C U S S I O N
The present current-and voltage -clamp study demonstrates that serotonin (50 -500 M) reduces the amplitude of the hyperpolarization-activated cationic current (I h ) in dopaminergic VTA neurons. This reduction was concentration-dependent and reversible with washout of serotonin. I h was also reduced by the 5-HT 2 agonist ␣-Me5-HT, and this effect was reversed by the 5-HT 2 antagonist ketanserin. The maximal I h current (measured at Ϫ130 mV) was reduced by serotonin, as was the maximal conductance (G h ). The normalized conductance (G h / G max ) curve showed that serotonin caused a negative shift in the voltage dependence of activation of I h . The serotonininduced reduction in I h amplitude was blocked by the nonspecific protein kinase inhibitor H-7 and the selective protein kinase C inhibitor chelerythrine, which suggests that it was mediated by protein kinase C. Consistent with this interpretation, the protein kinase C activator PDA mimicked and occluded the serotonin-induced reduction in I h amplitude. Specifically, PDA applied alone reduced I h amplitude. When serotonin and PDA were applied together, the effect on I h was less than additive, suggesting that they were reducing I h by a common mechanism. Taken together, these data demonstrate that serotonin reduces I h in dopaminergic VTA neurons and support the conclusion that this effect is mediated by 5-HT 2 receptors and protein kinase C.
The present study demonstrates that serotonin concentrations of 50 -500 M consistently decrease I h in dopaminergic neurons of the VTA, whereas serotonin concentrations Ͻ50 M, produced mixed effects. For example, our current-clamp experiments with 25 M serotonin showed no change in I h . Our voltage-clamp experiments testing 30 M serotonin in 16 VTA neurons showed that 37.5% of cells showed a decrease in I h , but an equal proportion showed an increase in I h with this lower serotonin concentration; the remaining 25% of neurons showed no change. The observation that a lower concentration of serotonin can increase I h in some dopaminergic VTA neurons is consistent with earlier reports that 40 M serotonin increased I h in dopaminergic neurons in the substantia nigra (Nedergaard et al. 1991) and that serotonin (30 -100 M) increased I h in 25% of dopaminergic VTA neurons tested (Pessia et al. 1994) . It should be noted, however, that in the present study, increases in I h were never observed with serotonin concentrations of Ն50 M, whereas the decrease in I h was clearly concentration dependent.
In view of estimates that the concentration of serotonin released at the synapse may reach the mM range (Bunin and Wightman 1998) , it is likely that the effects of the relatively high concentrations of serotonin (50 -500 M) observed in the FIG. 10 . PDA mimics and occludes the serotonin-induced reduction in I h . Bars indicate the mean Ϯ SE percent decrease in I h measured at Ϫ120 mV. The presence of DMSO vehicle alone, did not change I h amplitude (Ϫ1.7 Ϯ 5.0%, n ϭ 7). In the presence of DMSO, 300 M serotonin (5-HT) reduced the amplitude of I h (Ϫ35.3 Ϯ 9.1%, n ϭ 4). The addition of phorbol 12,13 diacetate (PDA, 2 M) in DMSO vehicle also reduced I h (Ϫ44.9 Ϯ 7.8%, n ϭ 3). In the presence of PDA (2 M) and serotonin (300 M), the amplitude of I h was decreased (Ϫ51.5 Ϯ 20.0%, n ϭ 3); however, this effect was much less than the sum of the effects of serotonin and PDA when tested alone. *, a significant difference from DMSO vehicle alone. (1-way ANOVA, P ϭ 0.006; Student-Newman Keuls post hoc tests P Ͻ 0.02). The decreases in I h measured in 5-HT, PDA, and 5-HT plus PDA were not significantly different from each other (P Ͼ 0.05).
present study are physiologically relevant. Furthermore, high concentrations of serotonin, such as were used in these studies, should have a faster onset of action than lower concentrations. In addition, serotonin reuptake blockers were not added to the superfusion medium, and, given active reuptake of serotonin present in brain slices, it is likely that the effective concentration of 5-HT at the receptor was lower than the concentration applied in the bath in our experiments. This is supported by the fact that 25 M ␣-Me5-HT, a 5-HT 2 agonist that is not a substrate for reuptake, was sufficient to significantly reduce I h amplitude. The size of the reduction in I h by 25 M ␣-Me5-HT was very similar to the reduction by 100 M serotonin, indicating the same effect could be produced by a fourfold lower concentration of ␣-Me5-HT.
The effectiveness of the 5-HT 2 agonist ␣-Me5-HT to reduce I h , and the reversal of this effect by the 5-HT 2 antagonist ketanserin, suggest that serotonergic reduction of I h is mediated by serotonin 5-HT 2 receptors. An ultrastructural study has shown that 5-HT 2A receptors are present on the dendrites and somata of dopaminergic VTA neurons (Doherty and Pickel 2000) . Because the action of serotonin at 5-HT 2 receptors is transduced by the phosphatidylinositol signal transduction system (Conn and Sanders-Bush 1984) , the identity of the receptor as 5-HT 2 is consistent with the antagonism of the effect of serotonin by protein kinase C inhibitor chelerythrine and the less selective protein kinase inhibitor H-7, and by the mimick-ing of the inhibitory effect of serotonin on I h by PDA. Taken together, these results support the hypothesis that serotonin, by acting at a 5-HT 2 receptor, causes the activation of protein kinase C, which then reduces I h amplitude. Additional studies will be necessary to determine how activation of protein kinase C reduces I h amplitude in dopaminergic VTA neurons.
The serotonin-induced inhibition of I h , observed in the present study in dopaminergic VTA neurons, has also been reported in cerebellar Purkinje cells (Li et al. 1993) . The effect of serotonin in Purkinje cells closely resembles the effect in dopaminergic VTA neurons described in the present paper. In both studies, serotonin induced a similar negative shift in the voltage dependence of activation of I h . Interestingly, the serotonin-induced inhibition of I h in Purkinje neurons was mimicked by the 5-HT 2 agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) (Li et al. 1993) .
In contrast, in most studies in the literature, serotonin-induced increase of I h has been observed. For example, serotonin increases I h in inferior olivary neurons, and this increase is mediated by 5-HT 2 receptors, as it is blocked by 5-HT 2 antagonist ketanserin and is mimicked by 5-HT 2 agonist DOI (Placantonakis et al. 2000) . In addition, serotonin increases I h in neurons in CA1 hippocampal pyramidal neurons (Gasparini and DiFrancesco 1999) and in neurons in the thalamus (Mc-Cormick and Pape 1990), nucleus prepositus hypoglossi (Bobker and Williams 1989) , and dorsal root ganglion (Car- FIG. 11. Blockade of h-current with ZD7288 increases the inhibitory response to dopamine. Firing rate of dopaminergic VTA neurons was measured with extracellular recording techniques (see METH-ODS) . A: ratemeter recording of firing rate in the absence of ZD7288. Each vertical line represents the average firing rate over a 5-s interval, and the horizontal bars indicate the duration of application of dopamine (1, 2, 5, or 10 M as labeled). Percent change in firing rate produced by dopamine was assessed by comparing the firing rate over a 1-min interval at the peak dopamine effect to the firing rate over a 1-min interval immediately prior to dopamine administration (see METHODS) . In this cell, 5 M dopamine produced a Ϫ7.7% decrease in firing and 10 M produced a Ϫ14.6% decrease in the firing rate. B: ratemeter recording of firing rate of the same cell as in A in the presence of 30 M ZD7288. In the presence of ZD7288, 5 M dopamine produced a Ϫ31.1% decrease in firing, and 10 M produced a Ϫ64.8% decrease in the firing rate. C: pooled concentrationresponse curve showing the mean change in firing rate produced by dopamine plotted as a function of dopamine concentration in the absence (black circle) and presence (black square) of 30 M ZD7288 (n ϭ 14). The effect of dopamine in the presence of ZD7288 was significantly greater than the effect of dopamine prior to administration of ZD7288 (2-way ANOVA, P Ͻ 0.001). denas et al. 1999); these effects of serotonin are mediated by an increase in cAMP. Conversely, receptors that inhibit adenylyl cyclase can reduce I h as demonstrated for opioids in nodose ganglion cells (Ingram and Williams 1994) and adenosine A1 receptor-mediated effects in thalamic (Pape 1992 ) and laterodorsal tegmental neurons (Rainnie et al. 1994 ). Because 5-HT 1 receptors inhibit adenylyl cyclase, we considered the possibility that the serotonin-induced reduction in I h that we observed in dopaminergic VTA neurons might be mediated by a reduction in cAMP.
In the present study, intracellular application of cAMP from the recording pipette caused a small increase in the amplitude of I h in all dopaminergic VTA neurons tested, indicating that cAMP had diffused into the cell and was exerting a positive modulatory effect on I h . This is consistent with previous reports that increasing intracellular cAMP can increase I h in dopaminergic neurons in the ventral tegmental area (Jiang et al. 1993 ) and substantia nigra (Cathala and Paupardin-Tritsch 1997) . Four genes encoding I h channels (HCN1-4) recently have been cloned; all have a conserved cyclic nucleotidebinding domain, but the isoforms differ in the strength of their modulation by cAMP (Santoro and Tibbs 1999; Santoro et al. 2000) . All four HCN genes are expressed in brain but show different regional localization (Moosmang et al. 1999; Robinson and Siegelbaum 2003) . It remains to be determined which HCN isoforms are present in dopaminergic VTA neurons and their sensitivity to modulation by cAMP relative to neurons in other brain areas.
If the serotonin-induced reduction in I h that we observed in dopaminergic VTA neurons was due to a decrease in cAMP, then increasing intracellular cAMP would be expected to prevent or significantly attenuate this inhibitory effect. Serotonin still reduced I h amplitude after intracellular administration of cAMP from the recording pipette and after bath application with the membrane-permeable cAMP analogue dibutyryl-cAMP. The effect of serotonin on I h in the presence of internal cAMP or external dibutyryl-cAMP was not significantly different from the effect of serotonin alone. These data suggest that the reduction in I h amplitude in dopaminergic VTA neurons is not consistent with inhibition of adenylyl cyclase.
The results of the present study suggest that the serotonergic reduction of I h in dopaminergic VTA neurons is mediated by protein kinase C. Specifically, serotonergic inhibition of I h was reduced by the nonspecific kinase inhibitor H-7 and the selective protein kinase C inhibitor chelerythrine. Furthermore, the phorbol ester PDA mimicked and occluded the serotonininduced reduction in I h . In addition to the reduction in I h amplitude, serotonin also caused a negative shift in the voltage dependence of activation of I h in dopaminergic VTA neurons. Interestingly, protein kinase C also has been implicated in the reduction of I h by neurotensin in dopamine neurons in the substantia nigra pars compacta (Cathala and Paupardin-Tritsch 1997) . While the size of the decrease in I h amplitude by neurotensin was similar to the serotonin-induced reduction in our study, neurotensin did not significantly change the voltage dependence of activation of I h (Cathala and Paupardin-Tritsch 1997) . In view of the fact that there are numerous isoforms of PKC (Way et al. 2000) , it is possible that neurotensin activates a different PKC isoform than serotonin. This might result in phosphorylation of different sites on the h-channel, or phosphorylation of a different subset of h-channels by the two neurotransmitters, leading to differences in their modulation of I h .
Because I h activates at membrane potentials negative to Ϫ70 mV in dopaminergic VTA neurons, it may not contribute much to their spontaneous firing rate (but see Seutin et al. 2001) . Interestingly, we have presented data in the present paper that reduction of I h can increase the inhibitory effect of dopamine on the spontaneous firing rate of dopaminergic VTA neurons. We have previously reported that serotonin, acting through 5-HT 2 receptors, also potentiates the inhibitory action of dopamine (Brodie and Bunney 1996) . As even low concentrations of dopamine (e.g., 1 M) were potentiated by ZD7288, the effect of I h blockade on dopamine inhibition probably did not require reducing the whole cell membrane potential to Ϫ70 mV because the cells were still spontaneously active. While further experiments will be necessary to uncover the precise mechanism of this action, it may be that the opening of the G-protein-coupled inwardly rectifying potassium channels (GIRKs) by the action of dopamine on D 2 receptors (Kim et al. 1995; Lacey et al. 1987 ) produces local membrane potentials negative to Ϫ70 mV, which causes the opening of h-channels in the vicinity of those GIRK channels. The inhibitory dopamine current would be shunted by the reduced membrane resistance due to the open h-channels, and the effect of the inhibitory dopamine current on the whole cell would be reduced. When I h is reduced by serotonin or ZD7288, the action of dopamine would not be attenuated by the opening of nearby h-channels and there would be relatively greater reduction of firing rate by dopamine.
The neuromodulatory role of serotonin may also extend to excitatory burst firing of dopaminergic neurons. Selective blockade of I h with ZD7288 has been shown to decrease spontaneous firing of midbrain dopamine neurons (Seutin et al. 2001 ) and, as hypothesized by those authors, I h may be more important when the membrane achieves more negative potentials, for example, during the afterhyperpolarization after action potential burst firing. After a burst, the afterhyperpolarization can achieve potentials negative to Ϫ70 mN, and the duration of this afterhyperpolarization may be reduced by the opening of h-channels. Reduction of I h by serotonin may prolong the postburst afterhyperpolarization and reduce excitability. This more sustained decrease in neuronal excitability might reduce the response to subsequent excitatory stimulation and limit the frequency of bursting in these neurons. As burst firing may be induced by excitatory amino acid neurotransmission (Johnson et al. 1992) , this action of serotonin could have a neuroprotective effect on mesencephalic dopamine neurons.
